Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.
NCT05848206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 251831
Last updated 2023-05-08
Summary
This was a retrospective cohort study utilizing IQVIA open-source pharmacy and medical claims data among patients with a sacubitril/valsartan (SAC/VAL) prescription transaction.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-11
- Primary Completion
- 2022-04-29
- Completion
- 2022-04-29
Countries
- United States
Study Locations
More Related Trials
-
Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure
NCT07023016 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
NCT00887588 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
NCT00294086 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.
NCT02970669 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
NCT02884206 ·Status: COMPLETED ·Phase: PHASE3
-
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
NCT02916160 ·Status: COMPLETED ·Phase: PHASE4
-
Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
NCT05545059 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
NCT00171106 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
NCT00241085 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension
NCT06604897 ·Status: ACTIVE_NOT_RECRUITING
-
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
NCT06273254 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
NCT06643819 ·Status: RECRUITING ·Phase: PHASE3
-
Hypertension and Cardiovascular Risk Factors
NCT00171782 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
NCT00902304 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
NCT01912534 ·Status: COMPLETED ·Phase: PHASE2
-
Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets
NCT06248112 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
NCT00171535 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912 ·Status: COMPLETED ·Phase: PHASE3
-
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
NCT00170924 ·Status: COMPLETED ·Phase: PHASE4
-
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
NCT00171093 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4
-
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
NCT06193187 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
NCT00241137 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
NCT00170989 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
NCT00333489 ·Status: COMPLETED ·Phase: PHASE4